{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:36:52Z","timestamp":1786628212596,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154180","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:05:12Z","timestamp":1782230712000},"page":"154180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Redirected T-cell cytotoxicity identifies BRD9-PTGES axis as an immune-sensitising vulnerability in ovarian cancer"],"prefix":"10.1016","volume":"829","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9971-949X","authenticated-orcid":false,"given":"Shanni","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9877-026X","authenticated-orcid":false,"given":"Bowen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154180_bib1","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2026.37.e78","article-title":"Comprehensive assessment of incidence, mortality, and lifetime risk of ovarian cancer: a global study with forecasts to 2050","author":"Jiang","year":"2026","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154180_bib2","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","article-title":"Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study","volume":"30","author":"Matulonis","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbrc.2026.154180_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1328651","article-title":"Targeting the immune microenvironment for ovarian cancer therapy","volume":"14","author":"Blanc-Durand","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154180_bib4","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.3390\/curroncol31070283","article-title":"The complex tumor microenvironment in ovarian cancer: therapeutic challenges and opportunities","volume":"31","author":"Garlisi","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbrc.2026.154180_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Sci (NY)"},{"key":"10.1016\/j.bbrc.2026.154180_bib6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/2326-6066.CIR-18-0193","article-title":"A high-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of antigen-specific cytotoxic T-lymphocyte tumor cell killing","volume":"6","author":"Lizotte","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbrc.2026.154180_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(23)00521-4","article-title":"T-cell-engaging bispecific antibodies in cancer","volume":"402","author":"van de Donk","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.154180_bib8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41416-020-01225-5","article-title":"Overcoming the challenges associated with CD3+ T-cell redirection in cancer","volume":"124","author":"Singh","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154180_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2326-6066.CIR-21-0407","article-title":"B7-H3 suppresses antitumor immunity via the CCL2-CCR2-M2 macrophage axis and contributes to ovarian cancer progression","volume":"10","author":"Miyamoto","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbrc.2026.154180_bib10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/2767-9764.CRC-23-0546","article-title":"Pan-cancer interrogation of B7-H3 (CD276) as an actionable therapeutic target across human malignancies","volume":"4","author":"Miller","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154180_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.tips.2025.08.008","article-title":"The B7-H3 (CD276) pathway: emerging biology and clinical therapeutics","volume":"46","author":"Corrigan","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2026.154180_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/acs.jmedchem.5b00256","article-title":"Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition","volume":"59","author":"Theodoulou","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154180_bib13","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41556-018-0221-1","article-title":"A non-canonical SWI\/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation","volume":"20","author":"Michel","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154180_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154180_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","article-title":"PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells","volume":"629","author":"Lacher","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154180_bib16","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1158\/2767-9764.CRC-23-0210","article-title":"Inhibition of microsomal prostaglandin E2 synthase reduces collagen deposition in melanoma tumors and may improve immunotherapy efficacy by reducing T-cell exhaustion","volume":"3","author":"Fukuda","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154180_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.2016.172","article-title":"CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer","volume":"115","author":"Bronger","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154180_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbrc.2026.154180_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.09.032","article-title":"Modular organization and assembly of SWI\/SNF family chromatin remodeling complexes","volume":"175","author":"Mashtalir","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154180_bib20","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1074\/jbc.RA117.001065","article-title":"Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI\/SNF chromatin remodeling subcomplexes","volume":"293","author":"Alpsoy","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154180_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1158\/0008-5472.CAN-25-0079","article-title":"Tumor-associated macrophages produce PGE2 to promote CD8+ T-cell exhaustion and drive resistance to PD-L1 blockade in microsatellite-stable colorectal cancer","volume":"86","author":"Fumet","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154180_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/14728222.2023.2285785","article-title":"The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential","volume":"27","author":"Steinmetz-Sp\u00e4h","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbrc.2026.154180_bib23","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1002\/anie.201611281","article-title":"Degradation of the BAF complex factor BRD9 by heterobifunctional ligands","volume":"56","author":"Remillard","year":"2017","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bbrc.2026.154180_bib24","doi-asserted-by":"crossref","first-page":"24848","DOI":"10.1021\/acs.jmedchem.5c01317","article-title":"Discovery of CFT8634, a potent, selective, and orally bioavailable heterobifunctional degrader of BRD9","volume":"68","author":"Jackson","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:00:45Z","timestamp":1786626045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26009447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"alternative-id":["S0006291X26009447"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154180","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redirected T-cell cytotoxicity identifies BRD9-PTGES axis as an immune-sensitising vulnerability in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154180"}}